GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Evonile Pharma Ltd

Evonile Pharma Ltd Sets Record Date for Rights Issue of Up to Rs. 9,000 Million

FUNDRAISE ▲ Positive Development MEDIUM RISK
📅 Filed on BSE: 04 Nov 2026, 07:46 PM IST  ·  BSE ID: 8679b2a1-a075-4b07-a11c-fbcd4fb22757
View Original BSE Filing (PDF)
💡
In Simple Terms
Evonile Pharma has set a date to decide who can buy new shares in a planned rights issue to raise funds.
🤖 AI Summary
  • Evonile Pharma Ltd sets November 11, 2026, as the record date for its rights issue.
  • Company aims to raise up to INR 9,000.00 million through issuance of partly paid shares.
  • The rights issue price is fixed at INR 860 per share.
  • Eligible shareholders will receive 5 rights equity shares for every 12 fully paid-up equity shares held.
🔢 Key Numbers - exact figures from BSE filing, not rounded
Rights Issue Size
INR 9,000.00 million
Issue Price
INR 860 /-
Total number of securities proposed to be issued
1,02,87,832
Issue Size (actual)
INR 8,847.54/- Million
Rights Entitlement Ratio
5:12
Record Date
Wednesday, November 11, 2026
Issue Opening Date
Thursday, November 19, 2026
Issue Closing Date
Thursday, December 03, 2026
🏢 How This Affects the Company
📈
Business Impact
The rights issue provides capital which can support business expansion or strategic initiatives, potentially enhancing market position upon successful deployment.
💰
Financial Impact
The capital infusion will increase the company's equity base and cash reserves, thereby strengthening its balance sheet and potentially reducing leverage.
⚠️
Risk Impact
A rights issue can dilute existing shareholders' stakes if they do not participate, and the terms of the issue reflect the company's current financial needs and market conditions.
👥 What This Means For Shareholders
✅
Action Required
Shareholders on record as of November 11, 2026, are eligible to participate in the rights issue as per their entitlement.
👤
Who Is Affected
All equity shareholders of Evonile Pharma Ltd as of November 11, 2026, will be entitled to subscribe to 5 rights equity shares for every 12 fully paid-up equity shares held.
🔍
Management Signal
The rights issue signals management's intent to raise substantial capital to fund future company growth and development.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Confirmation of application process for the rights issue.
Shareholder subscription rates for the rights issue.
Subsequent use of funds raised from the rights issue.
MEDIUM RISK Rights issue involves dilution and payment obligations, with success dependent on market conditions and shareholder participation.
💡 Investor Takeaway
Evonile Pharma Ltd sets November 11, 2026, as record date for rights issue of up to INR 9,000.00 million at INR 860 per share, with a 5:12 entitlement ratio.
⚖️ Strengths & Concerns

✅ Positives

  • Issue size of up to INR 9,000.00 million to fund growth and strengthen capital base.
  • Rights issue price fixed at INR 860 per share, offering clear terms to eligible shareholders.

⚠️ Concerns

  • Potential dilution for shareholders who do not subscribe to the rights issue.
  • The payment schedule requires funds to be paid in two tranches, impacting cash flow timing.
❓ Frequently Asked Questions
What is the record date for Evonile Pharma's rights issue?
The record date for determining eligible shareholders for Evonile Pharma's rights issue is Wednesday, November 11, 2026.
How much capital does Evonile Pharma plan to raise through the rights issue?
Evonile Pharma plans to raise an aggregate amount of up to INR 9,000.00 million through the rights issue.
What is the issue price for the rights equity shares of Evonile Pharma?
The issue price for the partly paid equity shares in the rights issue is fixed at INR 860 per share.
What is the rights entitlement ratio for Evonile Pharma shareholders?
Eligible equity shareholders are entitled to 5 Rights Equity Shares for every 12 fully paid-up Equity shares held as on the record date.
When does the rights issue open and close for Evonile Pharma?
The Rights Issue opens on Thursday, November 19, 2026, and closes on Thursday, December 03, 2026.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.